!function(s,a,e,v,n,t,z){if(s.saq)return;n=s.saq=function(){n.callMethod?n.callMethod.apply(n,arguments):n.queue.push(arguments)};if(!s._saq)s._saq=n;n.push=n;n.loaded=!0;n.version='1.0';n.queue=[];t=a.createElement(e);t.async=!0;t.data-privacy-src=v;z=a.getElementsByTagName(e)[0];z.parentNode.insertBefore(t,z)}(window,document,'script','https://tags.srv.stackadapt.com/events.js');saq('ts', 'hqvUkGggBAQuL-fcnFloOA');
In The News2026-07-15T17:55:57-04:00

In the News

Valiltramiprosate is an investigational agent and not approved for use anywhere in the world. Statements in news stories may be aspirational.

Newsletter

Sign up for updates

Get the latest Alzheon news in your inbox.

Not seeing the signup form? An ad or privacy blocker may be hiding it – email info@alzheon.com and we’ll add you to the list.

Alzheon, Inc.
111 Speen Street, Suite 306
Framingham, MA 01701, USA
508-861-7709

© 2026 Alzheon, Inc. All rights reserved.

Privacy PolicyContact
This website uses cookies and third-party services. By clicking "ACCEPT", you confirm that you have read and are agreeing to our privacy policy and the use of ALL cookies. ACCEPT
Go to Top